Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
16
Frequently Asked Questions
What is Market Cap of Lipocine Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lipocine Inc market cap is $15.66M.
What is the 52-week high for Lipocine Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lipocine Inc 52 week high is $6.17 as of September 09, 2025.
What is the 52-week low for Lipocine Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lipocine Inc 52 week low is $2.68 as of September 09, 2025.
What is Lipocine Inc stock price today?
Lipocine Inc stock price today is $2.91.
What was Lipocine Inc stock price yesterday?
Lipocine Inc stock price yesterday was $2.89.
What is the PE ratio of Lipocine Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lipocine Inc’s P/E ratio is -3.43.
What is the Price-to-Book ratio of Lipocine Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lipocine Inc P/B ratio is 0.9067.
What is the 50-day moving average of Lipocine Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lipocine Inc 50-day moving average is $3.11.
